Cited by 244Immune Response and InflammationSepsis Diagnosis and TreatmentInflammation biomarkers and pathways

Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis

Open access
Wurfel, Mark M., Gordon, Anthony C., Holden, Tarah D., Radella, Frank, Strout, Jeanna, Kajikawa, Osamu, Ruzinski, John T., Rona, Gail +18 more·2008·American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: Polymorphisms affecting Toll-like receptor (TLR)–mediated responses could predispose to excessive inflammation during an infection and contribute to an increased risk for poor outcomes in patients with sepsis. Objectives: To identify hypermorphic polymorphisms causing elevated TLR-mediated innate immune cytokine and chemokine responses and to test whether these polymorphisms are associated with increased susceptibility to death, organ dysfunction, and infections in patients with sepsis. Methods: We screened single-nucleotide polymorphisms (SNPs) in 43 TLR-related genes to identify variants affecting TLR-mediated inflammatory responses in blood from healthy volunteers ex vivo. The SNP associated most strongly with hypermorphic responses was tested for associations with death, organ dysfunction, and type of infection in two studies: a nested case–control study in a cohort of intensive care unit patients with sepsis, and a case–control study using patients with sepsis, patients with sepsis-related acute lung injury, and healthy control subjects. Measurements and Main Results: The SNP demonstrating the most hypermorphic effect was the G allele of TLR1−7202A/G (rs5743551), which associated with elevated TLR1-mediated cytokine production (P < 2 × 10−20). TLR1−7202G marked a coding SNP that causes higher TLR1-induced NF-κB activation and higher cell surface TLR1 expression. In the cohort of patients with sepsis TLR1−7202G predicted worse organ dysfunction and death (odds ratio, 1.82; 95% confidence interval, 1.07–3.09). In the case-control study TLR1−7202G was associated with sepsis-related acute lung injury (odds ratio, 3.40; 95% confidence interval, 1.59–7.27). TLR1−7202G also associated with a higher prevalence of gram-positive cultures in both clinical studies. Conclusions: Hypermorphic genetic variation in TLR1 is associated with increased susceptibility to organ dysfunction, death, and gram-positive infection in sepsis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.200803-462oc

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a large population of septic patients, those with a single nucleotide polymorphism (SNP) marking a hyperfunctioning variant of TLR1 had increased organ dysfunction and morbidity from Gram-positive bacteremia.

    “In a large population of septic patients, those with a single nucleotide polymorphism (SNP) marking a hyperfunctioning variant of TLR1 had increased organ dysfunction and morbidity from Gram-positive bacteremia (150).”

    From Into the Eye of the Cytokine Storm (2012) · cites this paper as [150]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 50 · Cited by 244

Research works printed but not linked: 1

  1. [11]Wurfel MM, Gordon AC, Holden TD, Radella F, Stratton S, Rona G, Strout J, Black RA, Nickerson DA, Walley KR, *et al.* Variation in the *tlr1* gene affects TLR1 surface expression and is associated with increased mortality in septic shock [abstract]. Am J Respir Crit Care Med 2007;175:A898. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am%20J%20Respir%20Crit%20Care%20Med&volume=175&publication_year=2007&pages=A898&)]

Authors
Wurfel, M. M., Gordon, A. C., Holden, T. D., Radella, F., Strout, J., Kajikawa, O., Ruzinski, J. T., Rona, G., Black, A. R., Stratton, S., Jarvik, G. P., Hajjar, A. M., Nickerson, D. A., Rieder, M., Sevransky, J., Maloney, J. P., Moss, M., Martin, G., Shanholtz1, C., Garcia1, J. G. N., Gao1, L., Brower, R., Barnes, K. C., Walley, K. R., Russell, J. A., & Martin, T. R.
Affiliations
  • University of Washington (US)
  • University of British Columbia (CA)
  • Veterans Health Administration (US)
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington
  • Johns Hopkins University (US)
  • University of Colorado Anschutz (US)
  • Emory University (US)
  • University of Maryland School of Medicine, Baltimore, Maryland
  • Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Illinois; and
  • Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2008-10-01
Volume
178
Issue
7
Pages
710-720
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2000189931
Cited by
244
References
50
Citations by year
2026: 5 · 2025: 5 · 2024: 1 · 2023: 3 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 8 · 2018: 5 · 2017: 13 · 2016: 14 · 2015: 12 · 2014: 25 · 2013: 21 · 2012: 19
FWCI
10.57
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5p50hl073994-05, UL1TR000454)
  • National Heart, Lung, and Blood Institute (P50HL073996, HL-074366, HL-073996, HL73994, HL629063, R01HL074366)
  • National Institute of Allergy and Infectious Diseases (U54AI057141, AI057141)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
TLR1, innate immunity, sepsis, organ dysfunction, mortality, NF-κB activation, cytokine production, Gram-positive bacterial infections, single nucleotide polymorphisms, genetic susceptibility
MeSH terms
Adult, Humans, Immunity, Innate, Prospective Studies, Respiratory Distress Syndrome, Case-Control Studies, Gram-Negative Bacterial Infections, Sepsis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genomics, Toll-Like Receptor 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review